Kytril is a drug that specializes in preventing nausea and vomiting resulting from chemotherapy and radiation therapy, especially in cases that require careful control of symptoms. It contains granisetron, which works by blocking serotonin receptors in the intestines and brain, which play a key role in activating the vomiting center. Kytril is characterized by its long-acting effect, providing the patient with relief from nausea for a period extending to many hours after the dose. It is taken either orally or by injection, depending on the condition. It may cause some side effects such as constipation or headache. Rarely, irregular heartbeat may occur. Therefore,
Kytril must be used under medical supervision, with careful monitoring of body functions during the treatment period.